Bak2Basics
Cart 0
Your cart is empty.
(401) 678-6420

Cannabidiol as a Potential Anti-Cancer Drug

Authored by Bak Basics
February 4, 2020

British Journal of Clinical Pharmacology reviewed several articles related to CBD modulation of tumorigenesis in several types of cancer. The cancers reviewed included breast cancer, glioma, leukemia, lymphoma, lung cancer, endocrine tumors and angiogenesis. The published article review in 2013 demonstrated the potential effect of CBD as an inhibitor of cancer growth and spread in vitro. With its low toxicity profile and summary of potential anti-tumor benefits, consideration of CBD as an adjunct to standard cancer therapy is a possibility.

Cannabidiol as a Potential Anticancer Drug - British Journal of Pharmacology February 2013

 

 





Add Comment

BAK 2 Basics, LLC
2845 Post Rd Suite 103
Warwick, RI 02886

Customerservice@bak2basicsllc.com

(401) 678-6420

**The products shown on this website have not been tested or approved by the FDA and are not intended to diagnose, prevent, treat or cure any condition. The information on this website is not intended to be used as medical advice. Be sure to consult with your doctor before starting any new supplements and if you experience any adverse reactions. We do NOT guarantee that you will get any results found anywhere online or on this website. We encourage everyone to do their own research to see how these types of products may benefit you. By using this site, you agree to follow the Privacy Policy and all Terms & Conditions printed on this site. Void where prohibited by law.These products should not be used if you are pregnant or nursing. Must be 21 years of age or older to purchase these products.No medical card or prescription required.**

© 2022 Bak2Basics. All Rights Reserved. Powered by Brave River Solutions
credit cards accepted